Schering-Plough: A good company to work for

You may have a tough time finding a job at Amgen, but Science magazine's latest survey places the biotech company as the third best biopharma in the world to work for. Genentech, which ruled the number one spot for six years running, has had to bow out and let Germany's Boehringer Ingelheim take the lead position. But perhaps the biggest surprise of the year belonged to Schering-Plough, which jumped from 17th last year to fourth this year. Why the big change? Schering-Plough puts its poll vault down to its emphasis on acting like a small company. Participants, meanwhile, say that a new spirit of openness, ethics and honesty can help transform the drug industry's shoddy public reputation.

- here's the report for more

Read more on: Amgen | Genentech | Boehringer Ingelheim | Schering-Plough

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.